Lacosamide as Add-On to Monotherapy in Patients with Partial-Onset Seizures: Interim Results of the Post-Marketing VITOBA Study (VImpaT Added to One Baseline AED)

被引：0
|
作者：
Noack-Rink, Matthias [1 ]
Mayer, Thomas [2 ]
Arnold, Stephan [3 ]
Kumke, Thomas [4 ]
Runge, Uwe [5 ]
机构：
[1] UCB Pharma GmbH, Monheim, Germany
[2] Sachs Epilepsiezentrum, Radeberg, Germany
[3] Neurozentrum Nymphenburg, Munich, Germany
[4] UCB Pharma GmbH, Monheim, Germany
[5] Univ Klinikum Greifswald, Greifswald, Germany
来源：
NEUROLOGY | 2012年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P06126
引用
收藏
页数：2
相关论文
共 19 条
  • [1] LACOSAMIDE AS ADD-ON TO MONOTHERAPY IN PATIENTS WITH PARTIAL-ONSET SEIZURES: INTERIM RESULTS OF THE POST-MARKETING VITOBA STUDY (VIMPAT ADDED TO ONE BASELINE AED)
    Noack-Rink, M.
    Mayer, T.
    Arnold, S.
    Kumke, T.
    Runge, U.
    EPILEPSIA, 2012, 53 : 185 - 186
  • [2] LACOSAMIDE ADDED TO A MONOTHERAPY IN EPILEPSY PATIENTS WITH PARTIAL-ONSET SEIZURES: FINAL ANALYSIS OF THE VITOBA STUDY
    Noack-Rink, M.
    Irrgang, V
    Ramirez, F.
    Mayer, T.
    Arnold, S.
    Runge, U.
    EPILEPSIA, 2014, 55 : 114 - 114
  • [3] A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial-onset seizures in daily clinical practice: The VITOBA study
    Runge, Uwe
    Arnold, Stephan
    Brandt, Christian
    Reinhardt, Fritjof
    Kuehn, Frank
    Isensee, Kathleen
    Ramirez, Francisco
    Dedeken, Peter
    Lauterbach, Thomas
    Noack-Rink, Matthias
    Mayer, Thomas
    EPILEPSIA, 2015, 56 (12) : 1921 - 1930
  • [4] AN ONGOING POSTMARKETING STUDY EVALUATING LACOSAMIDE AS ADJUNCTIVE THERAPY TO ONE BASELINE ANTIEPILEPTIC DRUG IN EPILEPSY PATIENTS: SP0973 VITOBA STUDY (VIMPAT ADDED TO ONE BASELINE AED)
    Runge, U.
    Mayer, T.
    Arnold, S.
    Kumke, T.
    Noack-Rink, M.
    EPILEPSIA, 2011, 52 : 156 - 157
  • [5] ESLICARBAZEPINE ACETATE AS ADD-ON TO ANTIEPILEPTIC MONOTHERAPY IN ADULTS WITH PARTIAL-ONSET SEIZURES (EPOS STUDY): ANALYSIS BY BASELINE ANTIEPILEPTIC DRUG
    Derambure, P.
    McMurray, R.
    Sousa, R.
    Holtkamp, M.
    EPILEPSIA, 2015, 56 : 54 - 54
  • [6] Effectiveness of eslicarbazepine acetate as add-on treatment to antiepileptic monotherapy in adults with partial-onset seizures (EPOS study): analysis by baseline antiepileptic drug
    Lawthom, C.
    McMurray, R.
    Sousa, R.
    Holtkamp, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 342 - 342
  • [7] LONG-TERM NON-INTERVENTIONAL STUDY OF LACOSAMIDE SAFETY AS ADD-ON THERAPY IN PATIENTS WITH EPILEPSY AND UNCONTROLLED PARTIAL-ONSET SEIZURES
    Steinhoff, B. J.
    Eckhardt, K.
    Doty, P.
    De Backer, M.
    Brunnert, M.
    Schulze-Bonhage, A.
    EPILEPSIA, 2014, 55 : 113 - 114
  • [8] Eslicarbazepine acetate as add-on treatment to antiepileptic monotherapy in adults with partial-onset seizures: German data of the EPOS study
    Losch, F.
    Holtkamp, M.
    McMurray, R.
    Sousa, R.
    Kockelmann, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 543 - 543
  • [9] REAL-WORLD DATA ON ESLICARBAZEPINE ACETATE AS ADD-ON TREATMENT TO ANTIEPILEPTIC MONOTHERAPY IN ADULTS WITH PARTIAL-ONSET SEIZURES: THE EPOS STUDY
    Holtkamp, M.
    McMurray, R.
    Sousa, R.
    Kockelmann, E.
    EPILEPSIA, 2015, 56 : 59 - 60
  • [10] Eslicarbazepine acetate as add-on treatment to antiepileptic monotherapy in adults with partial-onset seizures: real-world data from the EPOS study
    Holtkamp, M.
    McMurray, R.
    Sousa, R.
    Kockelmann, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 63 - 63
12